Angiotensin Converting Enzyme Inhibitors in Raynaud??s Phenomenon
- 1 December 1994
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 48 (6) , 864-867
- https://doi.org/10.2165/00003495-199448060-00003
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- [The use of Capoten in systemic scleroderma].1992
- Subjective and objective assessment of enalapril in primary Raynaud's phenomenon.Published by Wiley ,1991
- The effect of captopril on cutaneous blood flow in patients with primary Raynaud's phenomenonBritish Journal of Dermatology, 1987
- TREATMENT OF RAYNAUDS-PHENOMENON WITH CAPTOPRIL1987
- [Raynaud's disease treated with captopril (Capoten). A randomized double-blind cross-over study].1984
- Behandlung des Raynaud-Syndroms mit CaptoprilDeutsche Medizinische Wochenschrift (1946), 1984
- Long-term experience with captopril in severe hypertension.Published by Wiley ,1982
- Relief from digital vasospasm by treatment with captopril and its complete inhibition by serine proteinase inhibitors in Raynaud's phenomenon.BMJ, 1982
- Captopril in various forms of severe therapy-resistant hypertensionJournal of Molecular Medicine, 1981
- Reversal of Vascular and Renal Crises of Scleroderma by Oral Angiotensin-Converting-Enzyme BlockadeNew England Journal of Medicine, 1979